PAIN MANAGEMENT - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Pain Management in US$ Million by the following Product Segments: Pain Management Pharmaceuticals, Pain Management Devices, and Pain Management Services. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain. The report profiles 117 companies including many key and niche players such as -

AstraZeneca PLC
Eli Lilly and Company
Endo Pharmaceuticals
Glaxo Smithkline Plc
Johnson & Johnson
Merck & Co., Inc.


Click here to request a full list of companies covered in the report...

Code: MCP-1130
Price: $4500
Companies: 117
Pages: 727
Date: May 2012
Market Data Tables: 60

Complimentary Market Brief:


Request a Complimentary Copy of the Report Insights, Key Findings, Drivers, Trends, Program Sources, and Methodology.
Salutation:
First Name:
Last Name:
Email ID: (Domain Specific Email Required)
Company:
NOTE: Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSN etc. cannot be used

 TABLE OF CONTENTS


 
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Quantitative Techniques & Analytics.....I-3
Product Definition and Scope of Study.....I-3
Pain Management Pharmaceuticals.....I-3
Pain Management Devices.....I-3
Pain Management Services.....I-3
  
   Pain Management Market to Witness Steady Growth.....II-1
Factors Affecting Pain Management Industry.....II-1
Challenges Faced.....II-1
1$100
   Trends and Issues.....II-2
Future Prospects Bright for Pain Relieving Drug Market.....II-2
Generic Drugs Hog the Limelight.....II-2
Cox II Crisis Tarnishes Industry Growth.....II-2
Novel Therapies to Propel Opioid and Non-Opioid Therapies.....II-2
1$100
   Neuropathic Pain - Still an Underserved Market.....II-31$100
   Cyclin-dependent kinase 5 (Cdk5).....II-4
Drug Dynamics in the Migraine Market.....II-4
1$100
   Pain Pathways – Gain a Second Look.....II-5
Leading Players.....II-5
Generics to Inundate Pain Management Drug Market Further.....II-5
1$100
   Table 1: Leading Players in the Global Pain Management Pharmaceuticals Market (2011): Market Share Breakdown of Value Sales for Pfizer, Eli Lilly, Johnson & Johnson, Endo Pharma, Novartis and Others (includes corresponding Graph/Chart).....II-6
Status of Major Pipeline Drugs for Pain Management.....II-6
1$350
   Pain Management: An Overview.....II-7
Managing Pain.....II-7
What is Pain?.....II-7
Assessment of Pain.....II-7
1$100
   Pain Management.....II-81$100
   Pain Management for Neonates.....II-9
Pain Management in Kids.....II-9
Pain Management in Older Adult Surgical Patients.....II-9
1$100
   Pain Therapeutics – An Introduction.....II-101$100
   Treatment of Pain.....II-11
Pharmacologic Method.....II-11
1$100
   Non-pharmacological Method.....II-12
Invasive Procedures.....II-12
Palliative Care.....II-12
1$100
   Alternative Methods.....II-13
Acupuncture.....II-13
Biofeedback.....II-13
Bioelectromagnetic Therapy.....II-13
1$100
   Biomagnetism and Magnetotherapy.....II-14
Guided Imagery.....II-14
Manual/Massage Therapies.....II-14
Aromatherapy Massage.....II-14
Swedish Massage.....II-14
Deep Tissue Massage.....II-14
1$100
   Neuromuscular Therapy.....II-15
Myofascial Release.....II-15
Manual Lymph Drainage.....II-15
Cranial Sacral Therapy.....II-15
Reflexology.....II-15
1$100
   Naturopathy.....II-16
Relaxation Therapy.....II-16
Transcendental Meditation.....II-16
1$100
   Classification of Pain.....II-17
Acute Pain.....II-17
Postoperative pain.....II-17
Labor pain.....II-17
Visceral pain.....II-17
1$100
   Migraine.....II-18
Treatment of Migraine.....II-18
Chronic Pain.....II-18
Cancer pain.....II-18
1$100
   Back Pain.....II-19
Neuropathic Pain.....II-19
Arthritic Pain.....II-19
1$100
   HIV-Related Pain.....II-20
Diabetic Neuropathy.....II-20
1$100
   Osteo-and Rheumatoid Arthritis Pain.....II-21
Pain Management Products and Services.....II-21
Pain Management Pharmaceuticals.....II-21
Over-the-counter Drugs.....II-21
Acetaminophen.....II-21
Aspirin.....II-21
Ibuprofen.....II-21
1$100
   Ketoprofen.....II-22
Naproxen.....II-22
Pramoxine.....II-22
Counterirritants.....II-22
1$100
   Triethanolamine Salicylate (Trolamine).....II-23
Prescription Drugs.....II-23
Non-steroidal Anti-Inflammatories (NSAIDs).....II-23
Non-opioid Analgesics.....II-23
Opioid Analgesics.....II-23
2$125
   Pain Management Devices.....II-25
Electrical Spinal Cord Stimulators.....II-25
1$100
   Electrical Stimulus Devices.....II-26
Transcutaneous Electric Nerve Stimulators (TENS).....II-26
Patient-Controlled Analgesia Infusion Devices.....II-26
Pain Management Services.....II-26
Home Care/Providence Home Health.....II-26
1$100
   Providence Hospices.....II-27
Pain Management Centers and Clinics.....II-27
Pain Rehabilitation Programs.....II-27
1$100
   OTC Painkillers to Carry Conspicuous Safety Warnings.....II-28
Federal Regulatory Norms of Controlled Substances.....II-28
DEA Regulations.....II-28
1$100
   Venus Remedies to Unveil Aceclofenac OD.....II-29
Sandoz International Launches Metaxalone Tablets in US .....II-29
Covidien Unveils EXALGO™ Extended-Release Tablets.....II-29
1$100
   Bresslergroup Develops Dental Vibe for Pain-Free Dental Injections.....II-30
Competitive Technologies Launches Calmare® Medical Device.....II-30
Victory Pharma Unveils Naprelan Dose Card.....II-30
1$100
   BIOLASE Technology Launches Diolase 10™ Diode Laser .....II-31
Dr. Reddy's Laboratories Unveils Finrid Transdermal Patch.....II-31
Cumberland Pharmaceuticals Unveils Caldolor® in US .....II-31
1$100
   Tenscare Launches Iglove.....II-32
Piramal Launches BioElectronics' ActiPatch in India.....II-32
Victory Pharma to Introduce Supplementary NAPRELAN Products.....II-32
1$100
   Lannett Unveils Two New Products.....II-33
Glenmark Rolls Out Morphine Oral Solution in the US.....II-33
Acrux Introduces New NSAID Formulations.....II-33
Amrutanjan Healthcare Relaunches Amrutanjan Pain Balm.....II-33
ConvaTec Introduces SUR-FIT Natura® Low-Pressure Adaptor.....II-33
Cosman Medical Launches G4 Four-Output RF Generator.....II-33
1$100
   Origin BioMed Unveils Neuragen.....II-34
Biotanika Health Rolls Out Natural Product Range.....II-34
B. Braun Medical Introduces Curlin 6000 CMS.....II-34
Dynatronics Launches DynaPro Spinal Health System.....II-34
ProEthic Pharmaceuticals Unveils Ibudone.....II-34
1$100
   Endo Pharmaceuticals to Introduce New Dosage Strengths of OPANA®ER.....II-35
Dr. Reddy's Laboratories Unveils Supanac.....II-35
Troikaa Pharmaceuticals Rolls Out DYNAPAR AQ 1ml.....II-35
Janssen-Cilag International to Launch IONSYS™.....II-35
1$100
   Mallinckrodt Introduces Novel Pain Relieving Agent.....II-36
Shionogi Unveils Cancer Pain Management Drug.....II-36
NeuroTherm Launches RF Generators for Treatment of Heel Pain.....II-36
McNeil Brings Chewable TYLENOL® GoTabs Tablets.....II-36
1$100
   Barr Unveils Generic Version of ACTIQ®.....II-37
Orthofix Unveils e-PainCare.....II-37
Organon Innovates Org 25969.....II-37
Orthofix’s BREG Division Launches Polar Care Motorized Cold Therapy System.....II-37
Zynex Develops New Pain Management Device.....II-37
1$100
   Grünenthal’s Tapentadol Clears European Decentralised Procedure.....II-38
Stryker to Acquire Pain-Management Device Unit of Boston Scientific.....II-38
Axxess Pharma to Ink License Agreement for a New Prescription Drug.....II-38
Endo Pharmaceuticals Acquires HealthTronics.....II-38
1$100
   Purdue Pharma Secures FDA Approval for Transdermal System.....II-39
Discus Acquisition Takes Over Outstanding Shares of Javelin Pharmaceuticals.....II-39
Cannabis Science to Acquire Montana Pain Management.....II-39
1$100
   Roxro Pharma Receives FDA Approval for SPRIX™ Nasal Spray.....II-40
Ralfinamide Fails to Show Benefits in Phase IIb Trial.....II-40
NeuroTherm Acquires Smith & Nephew's Interventional Spine Pain Management
  Assets.....II-40
Horizon Therapeutics Merges with Nitec Pharma.....II-40
1$100
   Gentiva Takes Over Heart to Heart Hospice.....II-41
Millennium Laboratories Inks National Agreement with Aetna.....II-41
PatientsLikeMe Takes Over ReliefInsite.com.....II-41
1$100
   TeamHealth Hospital Staffing Firm Acquires Anesthetix Management.....II-42
CombinatoRx Merges with Neuromed Pharmaceuticals.....II-42
Roche Licenses P2X31 Receptor Program to Afferent Pharmaceuticals.....II-42
1$100
   Lannett Obtains FDA approval for Producing Hydromorphone Hydrochloride Tablets.....II-43
Anesiva Inks an Asset Purchase Agreement with PowderJect Technologies.....II-43
Millennium Laboratories Inks Agreement with Three Rivers Provider Network.....II-43
Cumberland Pharmaceuticals Partners with Phebra to Promote Caldolor®.....II-43
1$100
   Sciele Pharma Acquires Addrenex Pharmaceuticals.....II-44
Bioniche Pharma Acquires Injectable Drugs from Xanodyne.....II-44
NeurogesX Obtains FDA Approval for Qutenza™.....II-44
1$100
   Cerimon Acquires Development and Commercialization Rights for Diclofenac in
  Europe.....II-45
Hydra Biosciences Collaborates with Cubist.....II-45
Zambon Spa Inks a Licensing Agreement with Indena Spa.....II-45
1$100
   Pfizer Acquires Wyeth.....II-46
B. Braun Bags Contract from HealthTrust Purchasing Group.....II-46
QRxPharma Enters into Partnership with Patheon to Produce Clinical Supplies.....II-46
1$100
   Kimberly-Clark to Acquire I-Flow.....II-47
Kimberly-Clark Takes Over Pain Management Business of Baylis Medical.....II-47
WraSer Pharmaceuticals Purchases Trezix® from e5 Pharma.....II-47
TorreyPines Therapeutics Merges with Raptor Therapeutics.....II-47
1$100
   GSK Enters into Agreement with Dr Reddy's Laboratories.....II-48
Patterson Medical Acquires DJO’s Supply Catalog and Rehabilitation Equipment
  Business.....II-48
Mallinckrodt Acquires Licensing Rights from Neuromed.....II-48
Nuvo Research Enters into Licensing Agreement with Mallinckrodt.....II-48
1$100
   Bederra Plans to Take Over Neogenex.....II-49
Z-Cube Inks Deal with Yissum.....II-49
XenaCare Acquires US License for Homeopathic Treatment.....II-49
Symbios Ropes in Distributors to Market Pain Management Products Across US.....II-49
1$100
   Teikoku Pharma Takes Over Travanti Pharma.....II-50
Diamyd Licenses Endomorphin Technology.....II-50
Competitive Technologies and Life Episteme Enters into an Agreement.....II-50
Bederra Enters into Collaboration with Pain Management Center.....II-50
1$100
   Javelin Pharmaceuticals Signs Agreement with Therabel Pharma.....II-51
Biotanika Inks Deal with Xymogen.....II-51
HSR Clears Solvay Pharmaceuticals and Depomed's Licensing Agreement.....II-51
BioDelivery Sciences and Meda Ink an Agreement.....II-51
Endo Pharmaceuticals to Take Over Indevus Pharmaceuticals.....II-51
1$100
   Actavis US Acquires Kadian.....II-52
Labopharm Receives Approval from U.S. Food and Drug Administration.....II-52
Albert Acquisition Acquires Alpharma.....II-52
Sosei Group Re-acquires Commercialization Rights for AD 923.....II-52
Sun Pharmaceutical Industries Purchases Chattem Chemicals.....II-52
Piramal Healthcare Inks Agreement with Minrad International.....II-52
1$100
   AgION Technologies and Stryker’s Instruments Division Enter into Agreement.....II-53
Elder Pharmaceuticals and Global Energy Medicines Sign Agreement.....II-53
Wound Management Technologies to Take Over BioPharma Management Technologies.....II-53
NovaMed Purchases Stake in The Center for Specialized Surgery.....II-53
1$100
   RxElite Ends Agreement with Minrad International.....II-54
Johnson & Johnson Receives FDA Approval for Tapentadol.....II-54
Mundipharma International and Purdue Pharma Ink Alliance with Infinity.....II-54
Zynex Obtains CE Mark for IF8100 and IF8000 Pain-Managing Devices.....II-54
Competitive Technologies and Able Global Healthcare Ink an Agreement.....II-54
1$100
   National Surgical Hospitals Inks New Joint Venture.....II-55
Getting Ready and Winston Laboratories Merge.....II-55
Competitive Technologies and Biogene Pharma Ink an Agreement.....II-55
MEKT and ProtoKinetix Enter into Agreement.....II-55
Tronics Microsystems Takes Over MedTech Development.....II-55
1$100
   NSC Purchases Ardmore Regional Surgery Center and Kenwood Surgery Center.....II-56
Mallinckrodt and Purdue Pharma Sign Agreement.....II-56
Javelin Pharmaceuticals and Baxter Healthcare Enter into Agreement.....II-56
Competitive Technologies and Excel Life Sciences Ink an Agreement.....II-56
Theragenics to Buy NeedleTech Products.....II-56
1$100
   Wyeth Consumer Healthcare Inks Agreement with Procter & Gamble.....II-57
NovaMed Purchases Majority Stake in Interventional Pain Management Center.....II-57
Option Care Enterprises Takes Over CuraScript Infusion Pharmacy.....II-57
Eli Lilly Obtains FDA Approval for Cymbalta®.....II-57
Curlin Medical Receives Contract from Premier.....II-57
1$100
   EUSA Pharma Acquires Cytogen.....II-58
American Oriental Enters into Alliance with China Aoxing Pharmaceutical.....II-58
Treximet Bags Approval from FDA.....II-58
LMA International Takes Over Breg's Pain Management Operations.....II-58
1$100
   Hospira and HealthTrust Purchasing Group Enter into Agreement.....II-59
Hebei Aoxing Pharmaceutical Purchases Shijiazhuang Lerentang Pharmaceutical.....II-59
Bederra Signs Letter of Intent with Lumar Diagnostic Imaging.....II-59
Integrated Pain Solutions and Devon Health Services Sign Agreement.....II-59
1$100
   Maneesh Pharmaceuticals Purchases Smyle.....II-60
Eli Lilly and Glenmark Pharmaceuticals Ink an Agreement.....II-60
Orexo Takes Over Biolipox.....II-60
ReAble Therapeutics to Acquire Shares of IOMED.....II-60
1$100
   Integra LifeSciences Buys Assets of Pain Management Operations of Physician
  Industries.....II-61
CeNeS Obtains IND Clearance for M6G from FDA.....II-61
Infinity Acquisition Takes Over Life Without Pain.....II-61
1$100
   Neuromed to Acquire US Rights for Oros Hydromorphone from Alza.....II-62
China Aoxing to Acquire Chinese Pharmaceutical Company, Shijiazhuang Le Ren.....II-62
Vyteris Holdings to Acquire Lehigh Valley Technologies.....II-62
1$100
   Younger America Pockets Life Without Pain.....II-63
PainCare Divests Center for Pain Management.....II-63
Grand Slam Acquires IOMED.....II-63
Ligand Accomplishes Divesture of AVINZA.....II-63
CeNeS and Ergomed Collaborate for Phase II Trials of NMDA Antagonist CNS 5161.....II-63
1$100
   Sorenson Secures Approval to Market Ambulatory Infusion Pump in China.....II-64
PainCare Pockets CPMASC.....II-64
Moog Takes Over Mckinley Medical Corp.....II-64
PainCare Acquires REC, CareFirst Medical Associates.....II-64
1$100
   CLL Pharma Acquires Synt:em.....II-65
AstraZeneca Partners with Pozen to Bring Novel Pain Management Therapy.....II-65
Great Outdoors Acquires Somatic Systems Institute.....II-65
PainCare Partners with Solstice Neurosciences to Offer Pain Management in CD.....II-65
Elan Confers Eisai with European Rights of Prialt.....II-65
Evotec Partners with Apeiron Biologics to Bring Novel Pain Therapy.....II-65
1$100
   Alpaca Enterprises Acquires Neuroscience Therapy Corp.....II-66
PainCare Holdings Acquires Desert Pain Medicine Group......II-66
Wex Pharma Inks Agreement With Boston Children’s Hospital.....II-66
Glenmark Inks Agreement with LVT to Market Pain Management Products.....II-66
EKR Attains North American Marketing Rights for Gelclair.....II-66
Grand Slam Acquires Cefar Medical.....II-66
1$100
   Omeros Acquires Nura.....II-67
Hospira Inks Agreement with Premier.....II-67
Pain Therapeutics Enters into Alliance with King Pharmaceuticals.....II-67
Corgentech Merges with AlgoRx.....II-67
Elder Pharmaceuticals Ventures into the Indian Pain Management Market.....II-67
1$100
   Xanodyne Acquires Pharmaceutical Assets of aaiPharma.....II-68
Pro-Dex Acquires Dental Technology From IntraVantage.....II-68
Encore Medical Acquires Compex Technologies.....II-68
Sosei Acquires Arakis.....II-68
Corgentech Signs Definitive Merger Agreement With AlgoRx.....II-68
1$100
   Elder Pharmaceuticals Enters into Marketing Agreement with TRB Chemedica.....II-69
University Pain Management Center Signs Agreement with Somnia.....II-69
Entelos and Organon to Extend Rheumatoid Arthritis (RA) Collaboration.....II-69
NovaMed Establishes a New Pain Management Center at Indiana.....II-69
1$100
   AstraZeneca Plc. (UK).....II-70
Eli Lilly and Company (USA).....II-70
Endo Pharmaceuticals (USA).....II-70
GlaxoSmithkline Plc. (UK).....II-70
1$100
   Johnson & Johnson (USA).....II-71
Merck & Co., Inc. (USA).....II-71
1$100
   Novartis Pharmaceuticals Corp. (USA).....II-72
Pfizer, Inc. (USA).....II-72
Wyeth (USA).....II-72
1$100
   Purdue Pharma (USA).....II-73
Sanofi S.A (France).....II-73
1$100
   Table 2: World Recent Past, Current & Future Analysis for Pain Management by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017(includes corresponding Graph/Chart).....II-741$350
   Table 3: World Historic Review for Pain Management by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-751$350
   Table 4: World 15-Year Perspective for Pain Management by Geographic Region - Percentage Breakdown of Annual Revenue for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....II-761$350
   Table 5: World Recent Past, Current & Future Analysis for Pain Management Pharmaceuticals by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017(includes corresponding Graph/Chart).....II-771$350
   Table 6: World Historic Review for Pain Management Pharmaceuticals by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-781$350
   Table 7: World 15-Year Perspective for Pain Management Pharmaceuticals by Geographic Region - Percentage Breakdown of Annual Revenue for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....II-791$350
   Table 8: World Recent Past, Current & Future Analysis for Pain Management Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017(includes corresponding Graph/Chart).....II-801$350
   Table 9: World Historic Review for Pain Management Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008(includes corresponding Graph/Chart).....II-811$350
   Table 10: World 15-Year Perspective for Pain Management Devices by Geographic Region - Percentage Breakdown of Annual Revenue for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....II-821$350
   Table 11: World Recent Past, Current & Future Analysis for Pain Management Services by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017(includes corresponding Graph/Chart).....II-831$350
   Table 12: World Historic Review for Pain Management Services by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-841$350
   Table 13: World 15-Year Perspective for Pain Management Services by Geographic Region - Percentage Breakdown of Annual Revenue for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....II-851$350
   A. Market Analysis.....III-1
Pain Statistics in the US.....III-1
Industry Overview.....III-1
1$75
   Pain Management Therapies on the Rise.....III-2
Opioids Pain Management Market to Garner Sizeable Growth.....III-2
Safety Concerns Restrict Large Scale Adoption.....III-2
Measures to Thwart Drug Abuse.....III-2
1$75
   Market for Cancer Pain Therapeutics.....III-3
Leading Players/Brands.....III-3
Table 14: Leading OTC Pain Relievers in the US Market for Pain Management (2011) - Percentage Breakdown of Value Sales by Brand for Advil, Tylenol, Aleve, Bayer, Tylenol PM, Motrin IB, Excedrin, Tylenol Arthritis, Excedrin Migraine, Private label, and Others (includes corresponding Graph/Chart).....III-3
1$200
   Table 15: Leading Oral Pain Relievers in the US Market for Pain Management (2011) - Percentage Breakdown of Value Sales by Brand for Orajel, Anbesol, Baby Orajel, Colgate Peroxyl, Zilactin, Glyoxide, Hyland's, Dentek Temparin, Orajel Mouth Aid, and Others (includes corresponding Graph/Chart).....III-41$200
   B. Market Analytics.....III-5
Table 16: The US Recent Past, Current & Future Analysis for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-5
1$200
   Table 17: The US Historic Review for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-61$200
   Table 18: The US 15-Year Perspective for Pain Management by Segment - Percentage Breakdown of Annual Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2003, 2011 & 2017 (Includes corresponding graphs/chart).....III-71$200
   Market Analytics.....III-8
Table 19: Canadian Recent Past, Current & Future Analysis for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-8
1$200
   Table 20: Canadian Historic Review for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-91$200
   Table 21: Canadian 15-Year Perspective for Pain Management by Segment - Percentage Breakdown of Annual Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2003, 2011 &2017 (includes corresponding Graph/Chart).....III-101$200
   Market Analytics.....III-11
Table 22: Japanese Recent Past, Current & Future Analysis for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-11
1$200
   Table 23: Japanese Historic Review for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-121$200
   Table 24: Japanese 15-Year Perspective for Pain Management by Segment - Percentage Breakdown of Annual Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-131$200
   Market Analytics.....III-14
Table 25: European Recent Past, Current & Future Analysis for Pain Management by Geographic Region - France, Germany, Italy, UK, Spain, Russia & Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-14
1$200
   Table 26: European Historic Review for Pain Management by Geographic Region - France, Germany, Italy, UK, Spain, Russia & Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-151$200
   Table 27: European 15-Year Perspective for Pain Management by Geographic Region - Percentage Breakdown of Annual Revenue for France, Germany, Italy, UK, Spain, Russia & Rest of Europe Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-161$200
   Table 28: European Recent Past, Current & Future Analysis for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-171$200
   Table 29: European Historic Review for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed With Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-181$200
   Table 30: European 15-Year Perspective for Pain Management by Segment - Percentage Breakdown of Annual Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2003, 2011 &2017 (includes corresponding Graph/Chart).....III-191$200
   Market Analytics.....III-20
Table 31: French Recent Past, Current & Future Analysis for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-20
1$200
   Table 32: French Historic Review for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-211$200
   Table 33: French 15-Year Perspective for Pain Management by Segment - Percentage Breakdown of Annual Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-221$200
   Market Analytics.....III-23
Table 34: German Recent Past, Current & Future Analysis for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-23
1$200
   Table 35: German Historic Review for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-241$200
   Table 36: German 15-Year Perspective for Pain Management by Segment - Percentage Breakdown of Annual Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-251$200
   Market Analytics.....III-26
Table 37: Italian Recent Past, Current & Future Analysis for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-26
1$200
   Table 38: Italian Historic Review for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-271$200
   Table 39: Italian 15-Year Perspective for Pain Management by Segment - Percentage Breakdown of Annual Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-281$200
   A. Market Analysis.....III-29
Key Statistics Related to Pain Management in the UK.....III-29
1$75
   B. Market Analytics.....III-30
Table 40: The UK Recent Past, Current & Future Analysis for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-30
1$200
   Table 41: The UK Historic Review for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-311$200
   Table 42: The UK 15-Year Perspective for Pain Management by Segment - Percentage Breakdown of Annual Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-321$200
   Market Analytics.....III-33
Table 43: Spanish Recent Past, Current & Future Analysis for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-33
1$200
   Table 44: Spanish Historic Review for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-341$200
   Table 45: Spanish 15-Year Perspective for Pain Management by Segment - Percentage Breakdown of Annual Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-351$200
   Market Analytics.....III-36
Table 46: Russian Recent Past, Current & Future Analysis for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-36
1$200
   Table 47: Russian Historic Review for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-371$200
   Table 48: Russian 15-Year Perspective for Pain Management by Segment - Percentage Breakdown of Annual Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-381$200
   Market Analytics.....III-39
Table 49: Rest of Europe Recent Past, Current & Future Analysis for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-39
1$200
   Table 50: Rest of Europe Historic Review for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-401$200
   Table 51: Rest of Europe 15-Year Perspective for Pain Management by Segment - Percentage Breakdown of Annual Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2003, 2011 &2017 (includes corresponding Graph/Chart).....III-411$200
   A. Market Analysis.....III-42
India.....III-42
B. Market Analytics.....III-42
Table 52: Asia-Pacific Recent Past, Current & Future Analysis for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-42
1$200
   Table 53: Asia-Pacific Historic Review for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-431$200
   Table 54: Asia-Pacific 15-Year Perspective for Pain Management by Segment - Percentage Breakdown of Annual Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-441$200
   Market Analytics.....III-45
Table 55: Latin American Recent Past, Current & Future Analysis for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017(includes corresponding Graph/Chart).....III-45
1$200
   Table 56: Latin American Historic Review for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-461$200
   Table 57: Latin American 15-Year Perspective for Pain Management by Segment - Percentage Breakdown of Annual Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-471$200
   Market Analytics.....III-48
Table 58: Rest of World Recent Past, Current & Future Analysis for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-48
1$200
   Table 59: Rest of World Historic Review for Pain Management by Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-491$200
   Table 60: Rest of World 15-Year Perspective for Pain Management by Segment - Percentage Breakdown of Annual Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-501$200
  -Click here to request a full table of contents and more details on this project.